Clinical trial
Atrial Fibrillation in Beta-Thalassemia
NCT05508932 is registered in ClinicalTrials.gov with University Hospital of Ferrara as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Atrial Fibrillation in Beta-Thalassemia
- Lead sponsor
- University Hospital of Ferrara
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- September 1, 2022
- Completion date
- July 1, 2032
- Enrollment
- 350 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.